Cognition Therapeutics logo

Cognition Therapeutics Share Price (NASDAQ: CGTX)

$2.42

-0.06

(-2.42%)

Last updated on

Check the interactive Cognition Therapeutics Stock chart to analyse performance

Cognition Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.28
    Today's High:$2.55

    Day's Volatility :10.59%

  • 52 Weeks Low:$0.22
    52 Weeks High:$3.83

    52 Weeks Volatility :94.2%

Cognition Therapeutics Stock Returns

PeriodCognition Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
664.98%
3.6%
0.0%
6 Months
463.43%
-7.7%
0.0%
1 Year
282.49%
-12.6%
0.0%
3 Years
23.1%
10.2%
-4.1%

Cognition Therapeutics, Inc. Key Stats

Check Cognition Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.48
Open
$2.57
Today's High
$2.55
Today's Low
$2.28
Market Capitalization
$182.2M
Today's Volume
$5.3M
52 Week High
$3.83
52 Week Low
$0.222301
Revenue TTM
$0.0
EBITDA
$-52.9M
Earnings Per Share (EPS)
$-0.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-219.68%

Stock Returns calculator for Cognition Therapeutics Stock including INR - Dollar returns

The Cognition Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cognition Therapeutics investment value today

Current value as on today

₹3,89,411

Returns

₹2,89,411

(+289.41%)

Returns from Cognition Therapeutics Stock

₹2,84,127 (+284.13%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cognition Therapeutics Stock

-1.27%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Cognition Therapeutics Shares from India has dropped by -1.27% over the past 30 days, indicating reduced transactional activity.

146%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cognition Therapeutics Stock from India on INDmoney has increased by 146% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cognition Therapeutics, Inc.

  • Name

    Holdings %

  • BIOS CAPITAL MANAGEMENT, LP

    9.24%

  • Vanguard Group Inc

    2.01%

  • Acadian Asset Management LLC

    1.55%

  • Chescapmanager LLC

    0.77%

  • Voss Capital LLC

    0.69%

  • Geode Capital Management, LLC

    0.57%

Analyst Recommendation on Cognition Therapeutics Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Cognition Therapeutics(by analysts ranked 0 to 5 stars)

Cognition Therapeutics Share Price Target

What analysts predicted

Upside of 34.3%

Target:

$3.25

Current:

$2.42

Cognition Therapeutics share price target is $3.25, a slight Upside of 34.3% compared to current price of $2.42 as per analysts' prediction.

Cognition Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, CGTX stock has moved up by 314.0%
  • CGTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 97.7%

Cognition Therapeutics Technicals Summary

Sell

Neutral

Buy

Cognition Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Cognition Therapeutics, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cognition Therapeutics, Inc. logo
263.35%
463.43%
282.49%
23.1%
-81.01%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Organization
Cognition Therapeutics
Employees
25
CEO
Ms. Lisa Ricciardi
Industry
Services

Key Management of Cognition Therapeutics, Inc.

NameTitle
Ms. Lisa Ricciardi
CEO, President & Director
Mr. John Brendan Doyle
Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.
Chief Medical Officer and Head of R&D
Dr. Steven A. Weissman Ph.D.
VP & Head of CMC
Ms. Anita Cornet
Head of Quality
Mr. Bobby Horn
Corporate Controller

Important FAQs about investing in CGTX Stock from India :

What is Cognition Therapeutics share price today?

Cognition Therapeutics share price today is $2.42 as on at the close of the market. Cognition Therapeutics share today touched a day high of $2.55 and a low of $2.28.

What is the 52 week high and 52 week low for Cognition Therapeutics share?

Cognition Therapeutics share touched a 52 week high of $3.83 and a 52 week low of $0.22. Cognition Therapeutics stock price today i.e. is closed at $2.42, lower by 36.81% versus the 52 week high.

How to invest in Cognition Therapeutics Stock (CGTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cognition Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cognition Therapeutics Shares that will get you 0.6198 shares as per Cognition Therapeutics share price of $2.42 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cognition Therapeutics Stock (CGTX) from India?

Indian investors can start investing in Cognition Therapeutics (CGTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cognition Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cognition Therapeutics share’s latest price of $2.42 as on August 30, 2025 at 1:29 am IST, you will get 4.1322 shares of Cognition Therapeutics. Learn more about fractional shares .

What are the returns that Cognition Therapeutics has given to Indian investors in the last 5 years?

Cognition Therapeutics stock has given -81.01% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?